Nutrient Regulation of Cell Physiology by O-GlcNAcylation
Nutrient Regulation of Cell Physiology by O-GlcNAcylation
批准号:
9329448
负责人:
GERALD Warren HART
金额:
$31.48万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
已结题
起止时间:
2016-08-10 至 2020-07-31
关键词:
AffectAffinityAgingAlzheimer&aposs DiseaseBindingCardiovascular DiseasesCatalytic DomainCell CycleCell NucleusCell physiologyCellsChromatinChronic DiseaseComplexCytoplasmCytoplasmic ProteinDNADNA BindingDNA MethylationDNA Modification MethylasesDNA-Directed RNA PolymeraseDataDiabetes MellitusDiseaseEatingEnzymesEpigenetic ProcessEtiologyGene ExpressionGene TargetingGenesGenetic TranscriptionGlucoseGoalsHeat-Shock ResponseHistonesHoloenzymesHumanKineticsLengthLifeLymphocyte ActivationMalignant NeoplasmsMammalsMediatingMethodsMitochondrial ProteinsModificationMolecularNerve DegenerationNuclear ProteinNuclear ProteinsNutrientO-GlcNAc transferasePaperPeptidesPhosphorylationPhosphotransferasesPlantsPlayPost-Translational Protein ProcessingPropertyProtein MicrochipsProteinsProteomicsRNA Polymerase IIRegulationRoleSignal TransductionSiteSpecificityStimulusStressSubstrate SpecificityTAF1 geneTATA-Box Binding ProteinTherapeuticToxic effectTranscriptional RegulationWorkblood glucose regulationcircadian pacemakerin vivoinsightknock-downmutantoverexpressionpromoterprotein Bprotein aminoacid sequenceresponsesensorstoichiometrysugartherapeutic developmenttraffickingtranscription factortranscription factor S-II
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The cycling of N-acetylglucosamine on Ser(Thr) residues (O-GlcNAcylation) of nuclear, cytoplasmic and
mitochondrial proteins serves as a nutrient sensor to regulate signaling, transcription, and cellular
physiology. Abnormal O-GlcNAcylation underlies the etiology of diabetes, cancer and Alzheimer's disease.
O-GlcNAcylation regulates nearly every aspect of transcription, including RNA polymerase II, histones, DNA
methyltransferases, and nearly all transcription factors. Yet we know very little about the mechanisms
involved. TATA-binding protein (TBP) is amongst the most important components of the transcription
machinery. Our recent studies indicate that TBP regulated by O-GlcNAcylation in response to nutrients.
O-GlcNAcylation has extensive crosstalk with protein phosphorylation and other modifications. However,
unlike phosphorylation, which is catalyzed by hundreds of kinases, there is only one highly conserved gene
encoding O-GlcNAc transferase (OGT). Nonetheless, OGT site-specifically modifies thousands of proteins.
Our data indicate that OGT's substrate specificity is not only determined by its specificity for peptide
sequence, but also by its transient associations with other proteins, which dynamically target it to specific
substrates. OGT targeting interactions are largely mediated by its tetratricopeptide repeats (TPRs). OGT
missing TPRs remains active against small peptides, but has poor activity against full-length proteins.
Herein we will investigate two major questions related to O-GlcNAcylation: Specific Aim 1: Continue to
Study Glucose Regulation of TATA-binding protein (TBP) via its O-GlcNAcylation. Hypothesis: At
certain promoters, glucose regulates TBP DNA-binding and its ability to bend DNA by altering its O-
GlcNAcylation. We will systematically elucidate mechanisms and functions of this nutrient regulation of TBP.
Three goals: A. Roles of O-GlcNAcylation in the molecular and cellular properties of TBP? B. Roles of O-
GlcNAc in TBP's Interactions in the Transcription Cycle. C. O-GlcNAc's In Vivo Roles in TBP-mediated
Gene Expression. Specific Aim 2: Continue to Elucidate How OGT is Specifically Targeted to
Thousands of Different Protein Substrates? Hypothesis: OGT achieves a high degree of specificity not
only by its recognition of peptide sequence, but also by it being targeted to substrates by accessory
proteins. This Aim will systematically evaluate both the general and specific roles of OGT binding partners
in OGT's activities toward its many substrates.
Given O-GlcNAc's importance to mechanisms of chronic disease, such as glucose toxicity in diabetes,
cancer and neurodegeneration, elucidation of these mechanisms will not only be key to understanding
transcription and signaling, also to uncovering new avenues for therapeutics.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Regulation of Translation by O-GlcNAc - Resubmission 03-05-2020
-
批准号:10308411
-
项目类别:
-
资助金额:$49.78万
-
财政年份:2020
-
负责人:GERALD Warren HART
-
依托单位:
Regulation of Translation by O-GlcNAc - Resubmission 03-05-2020
-
批准号:10533317
-
项目类别:
-
资助金额:$49.78万
-
财政年份:2020
-
负责人:GERALD Warren HART
-
依托单位:
Nutrient Regulation of Cell Physiology by O-GlcNAcylation
-
批准号:10458006
-
项目类别:
-
资助金额:$28.73万
-
财政年份:2016
-
负责人:GERALD Warren HART
-
依托单位:
Nutrient Regulation of Cell Physiology by O-GlcNAcylation
-
批准号:10261390
-
项目类别:
-
资助金额:$28.71万
-
财政年份:2016
-
负责人:GERALD Warren HART
-
依托单位:
Nutrient Regulation of Cell Physiology by O-GlcNAcylation
-
批准号:10668984
-
项目类别:
-
资助金额:$28.72万
-
财政年份:2016
-
负责人:GERALD Warren HART
-
依托单位:
Nutrient Regulation of Cell Physiology by O-GlcNAcylation
-
批准号:9754184
-
项目类别:
-
资助金额:$28.88万
-
财政年份:2016
-
负责人:GERALD Warren HART
-
依托单位:
"Glycosciences Skills Development "
-
批准号:8183699
-
项目类别:
-
资助金额:$5.71万
-
财政年份:2011
-
负责人:GERALD Warren HART
-
依托单位:
Administrative Core
-
批准号:8183684
-
项目类别:
-
资助金额:$10.65万
-
财政年份:2011
-
负责人:GERALD Warren HART
-
依托单位:
Glycoconjugates and Cardiovascular Disease
-
批准号:8669110
-
项目类别:
-
资助金额:$251.32万
-
财政年份:2011
-
负责人:GERALD Warren HART
-
依托单位:
Glycoconjugates and Cardiovascular Disease
-
批准号:8072358
-
项目类别:
-
资助金额:$243.63万
-
财政年份:2011
-
负责人:GERALD Warren HART
-
依托单位:
Crosstalk Between 0-GlcNAcylation and Phosphorylation in Diabetic Cardiomyopathy
-
批准号:8183667
-
项目类别:
-
资助金额:$32.67万
-
财政年份:2011
-
负责人:GERALD Warren HART
-
依托单位:
Glycoconjugates and Cardiovascular Disease
-
批准号:8289623
-
项目类别:
-
资助金额:$244.69万
-
财政年份:2011
-
负责人:GERALD Warren HART
-
依托单位:
Glycoconjugates and Cardiovascular Disease
-
批准号:9067492
-
项目类别:
-
资助金额:$225.94万
-
财政年份:2011
-
负责人:GERALD Warren HART
-
依托单位:
Glycoconjugates and Cardiovascular Disease
-
批准号:8477248
-
项目类别:
-
资助金额:$236.62万
-
财政年份:2011
-
负责人:GERALD Warren HART
-
依托单位:
Shared Resource Cores
-
批准号:8183701
-
项目类别:
-
资助金额:$62.86万
-
财政年份:2011
-
负责人:GERALD Warren HART
-
依托单位:
Glycoconjugates and Cardiovascular Disease
-
批准号:8853915
-
项目类别:
-
资助金额:$247.05万
-
财政年份:2011
-
负责人:GERALD Warren HART
-
依托单位:
Glycoconjugates and Cardiovascular Disease
-
批准号:8656256
-
项目类别:
-
资助金额:$5.18万
-
财政年份:2011
-
负责人:GERALD Warren HART
-
依托单位:
Mechanisms of Glucose Toxicity
-
批准号:7762380
-
项目类别:
-
资助金额:$49.2万
-
财政年份:2010
-
负责人:GERALD Warren HART
-
依托单位:
O-GlcNAc:Developing New Tool for Assessment of Glycemia
-
批准号:7491662
-
项目类别:
-
资助金额:$46.01万
-
财政年份:2005
-
负责人:GERALD Warren HART
-
依托单位:
O-GlcNAc:Developing New Tool for Assessment of Glycemia
-
批准号:6928686
-
项目类别:
-
资助金额:$34.32万
-
财政年份:2005
-
负责人:GERALD Warren HART
-
依托单位:
海外基金